Discovery & Development

mAbs are an important growth area for the biopharma industry – so we need more effective purification technologies.

Products are becoming increasingly complex and we need to get better at recognizing the strategies with the best advantages.

Antibody drug conjugates have not yet lived up to their potential, but there is hope – if we turn to the right solutions and techniques.

Streamlined workflows help scientists plot a course for painless peptide mapping

The path to market for a biosimilar involves an abbreviated approval process, focused on proving “biosimilarity”.

Why does the full potential of biosimilars remain untapped? Four experts weigh in.

Rare diseases aren’t the only field that can benefit from repurposing – the eye is also often overlooked.

Drug repurposing can benefit many areas of drug discovery – particularly rare diseases.

Caffeine isn’t just a catalyst to get you moving in the morning – it can also help create polymers for drug delivery.

New data protection regulations are coming.